Nutraceutical potential of exosome-like nanoparticles derived from Boehmeria japonica in inflammatory bowel disease

Despite the recent advances in treatment, some patients with inflammatory bowel disease (IBD) experience insufficient disease management and adverse side effects, necessitating the development of novel therapeutic strategies. We investigated the therapeutic efficacy of exosome-like nanoparticles (NP...

Full description

Bibliographic Details
Main Authors: Woo Sik Kim, Seo Jun Lee, Ki-Won Shin, Hyeon Jin Lee, Ji Young Park, In Chul Lee, Hyung-Jun Kwon, Hyung Jae Jeong, Bong-Sik Yun, Young Bae Ryu
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464624000094
_version_ 1797356116442611712
author Woo Sik Kim
Seo Jun Lee
Ki-Won Shin
Hyeon Jin Lee
Ji Young Park
In Chul Lee
Hyung-Jun Kwon
Hyung Jae Jeong
Bong-Sik Yun
Young Bae Ryu
author_facet Woo Sik Kim
Seo Jun Lee
Ki-Won Shin
Hyeon Jin Lee
Ji Young Park
In Chul Lee
Hyung-Jun Kwon
Hyung Jae Jeong
Bong-Sik Yun
Young Bae Ryu
author_sort Woo Sik Kim
collection DOAJ
description Despite the recent advances in treatment, some patients with inflammatory bowel disease (IBD) experience insufficient disease management and adverse side effects, necessitating the development of novel therapeutic strategies. We investigated the therapeutic efficacy of exosome-like nanoparticles (NPs) derived from Boehmeria japonica (BJ-NPs) in treating IBD. These BJ-NPs increased immunosuppressive cytokine IL-10 production (p < 0.001) in mature dendritic cells (DCs) and reduced the levels of pro-inflammatory cytokines and surface molecules. Moreover, BJ-NP-treated DCs exhibited decreased immunostimulatory capacity for inducing activation of Th1 and Th17 subsets while promoting regulatory T cell activity. In a colitis animal model, BJ-NP administration mitigated weight loss (p < 0.001 at 4–10 days), improved disease activity index scores (p < 0.001 at 6–10 days), reduced colon length (p < 0.001), and ameliorated histological features. These findings suggest that BJ-NPs can be used as nutraceutical or therapeutic agent for various inflammatory diseases, including IBD.
first_indexed 2024-03-08T14:20:58Z
format Article
id doaj.art-47ec38b5f22a403aa456905a849763b6
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-03-08T14:20:58Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-47ec38b5f22a403aa456905a849763b62024-01-14T05:37:32ZengElsevierJournal of Functional Foods1756-46462024-01-01112106007Nutraceutical potential of exosome-like nanoparticles derived from Boehmeria japonica in inflammatory bowel diseaseWoo Sik Kim0Seo Jun Lee1Ki-Won Shin2Hyeon Jin Lee3Ji Young Park4In Chul Lee5Hyung-Jun Kwon6Hyung Jae Jeong7Bong-Sik Yun8Young Bae Ryu9Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeollabuk-do 56212, Republic of KoreaFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeollabuk-do 56212, Republic of Korea; Division of Biotechnology and Advanced Institute of Environment and Bioscience, College of Environmental and Bioresource Sciences, Jeonbuk National University, Iksan-si, Jeonbuk 54596, Republic of KoreaFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeollabuk-do 56212, Republic of Korea; Department of Medical Science, College of Medicine, Chungnam National University, Daejeon 34134, Republic of KoreaFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeollabuk-do 56212, Republic of Korea; Department of Medical Science, College of Medicine, Chungnam National University, Daejeon 34134, Republic of KoreaFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeollabuk-do 56212, Republic of KoreaFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeollabuk-do 56212, Republic of KoreaFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeollabuk-do 56212, Republic of KoreaFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeollabuk-do 56212, Republic of KoreaDivision of Biotechnology and Advanced Institute of Environment and Bioscience, College of Environmental and Bioresource Sciences, Jeonbuk National University, Iksan-si, Jeonbuk 54596, Republic of Korea; Corresponding authors at: Division of Biotechnology and Advanced Institute of Environment and Bioscience, Jeonbuk National University, Iksan-si, Jeollabuk-do 54596, Republic of Korea.Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Jeollabuk-do 56212, Republic of Korea; Corresponding authors at: Division of Biotechnology and Advanced Institute of Environment and Bioscience, Jeonbuk National University, Iksan-si, Jeollabuk-do 54596, Republic of Korea.Despite the recent advances in treatment, some patients with inflammatory bowel disease (IBD) experience insufficient disease management and adverse side effects, necessitating the development of novel therapeutic strategies. We investigated the therapeutic efficacy of exosome-like nanoparticles (NPs) derived from Boehmeria japonica (BJ-NPs) in treating IBD. These BJ-NPs increased immunosuppressive cytokine IL-10 production (p < 0.001) in mature dendritic cells (DCs) and reduced the levels of pro-inflammatory cytokines and surface molecules. Moreover, BJ-NP-treated DCs exhibited decreased immunostimulatory capacity for inducing activation of Th1 and Th17 subsets while promoting regulatory T cell activity. In a colitis animal model, BJ-NP administration mitigated weight loss (p < 0.001 at 4–10 days), improved disease activity index scores (p < 0.001 at 6–10 days), reduced colon length (p < 0.001), and ameliorated histological features. These findings suggest that BJ-NPs can be used as nutraceutical or therapeutic agent for various inflammatory diseases, including IBD.http://www.sciencedirect.com/science/article/pii/S1756464624000094Boehmeria japonicaPlant-derived exosome-like nanoparticlesDendritic cellsImmune toleranceInflammatory bowel disease
spellingShingle Woo Sik Kim
Seo Jun Lee
Ki-Won Shin
Hyeon Jin Lee
Ji Young Park
In Chul Lee
Hyung-Jun Kwon
Hyung Jae Jeong
Bong-Sik Yun
Young Bae Ryu
Nutraceutical potential of exosome-like nanoparticles derived from Boehmeria japonica in inflammatory bowel disease
Journal of Functional Foods
Boehmeria japonica
Plant-derived exosome-like nanoparticles
Dendritic cells
Immune tolerance
Inflammatory bowel disease
title Nutraceutical potential of exosome-like nanoparticles derived from Boehmeria japonica in inflammatory bowel disease
title_full Nutraceutical potential of exosome-like nanoparticles derived from Boehmeria japonica in inflammatory bowel disease
title_fullStr Nutraceutical potential of exosome-like nanoparticles derived from Boehmeria japonica in inflammatory bowel disease
title_full_unstemmed Nutraceutical potential of exosome-like nanoparticles derived from Boehmeria japonica in inflammatory bowel disease
title_short Nutraceutical potential of exosome-like nanoparticles derived from Boehmeria japonica in inflammatory bowel disease
title_sort nutraceutical potential of exosome like nanoparticles derived from boehmeria japonica in inflammatory bowel disease
topic Boehmeria japonica
Plant-derived exosome-like nanoparticles
Dendritic cells
Immune tolerance
Inflammatory bowel disease
url http://www.sciencedirect.com/science/article/pii/S1756464624000094
work_keys_str_mv AT woosikkim nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease
AT seojunlee nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease
AT kiwonshin nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease
AT hyeonjinlee nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease
AT jiyoungpark nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease
AT inchullee nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease
AT hyungjunkwon nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease
AT hyungjaejeong nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease
AT bongsikyun nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease
AT youngbaeryu nutraceuticalpotentialofexosomelikenanoparticlesderivedfromboehmeriajaponicaininflammatoryboweldisease